Currencies / LXRX
LXRX: Lexicon Pharmaceuticals Inc
1.10
USD
0.05
(4.35%)
LXRX exchange rate has changed by -4.35% for today. During the day, the instrument was traded at a low of 1.09 and at a high of 1.15.
Follow Lexicon Pharmaceuticals Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
LXRX News
- Lexicon Pharmaceuticals’ Strategic Retrenchment Will Take Years To Show Results (LXRX)
- Lexicon (LXRX) Upgraded to Buy: Here's What You Should Know
- Jefferies raises Lexicon Pharmaceuticals stock price target to $0.85
- Lexicon Q2 2025 slides: Strategic pivot yields profit as pipeline advances
- Lexicon Pharmaceuticals (LXRX) Q2 Earnings and Revenues Top Estimates
- Lexicon earnings beat by $0.10, revenue topped estimates
- Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings and Revenue Estimates
- Lexicon Pharmaceuticals regains Nasdaq compliance
- Lexicon Pharmaceuticals regains Nasdaq compliance for minimum bid price
- Lexicon Q1 2025 slides: EPS beat, revenue miss, strategic partnerships advance
- H.C. Wainwright reiterates buy rating on Lexicon Pharmaceuticals stock
- Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA)
- Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
- Novo signs $812 million weight-loss drug license deal with US biotech Deep Apple
- Lexicon Pharmaceuticals surges 67% following InvestingPro’s Fair Value signal
- Lexicon Pharmaceuticals at Jefferies Conference: Strategic Partnerships and Pipeline Progress
- Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
- Lexicon at H.C. Wainwright Conference: Strategic Pipeline Developments
- SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
- Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price
- Top 2 Health Care Stocks That May Crash This Month - Lexicon Pharmaceuticals (NASDAQ:LXRX), Amarin Corp (NASDAQ:AMRN)
- US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst - Babcock & Wilcox (NYSE:BW), AAR (NYSE:AIR)
- Lexicon's Drug Discovery Engine Validated By Novo's Obesity Drug Deal
- Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected - Lexicon Pharmaceuticals (NASDAQ:LXRX), DBV Technologies (NASDAQ:DBVT)
Daily Range
1.09
1.15
Year Range
0.28
2.18
- Previous Close
- 1.15
- Open
- 1.13
- Bid
- 1.10
- Ask
- 1.40
- Low
- 1.09
- High
- 1.15
- Volume
- 1.227 K
- Daily Change
- -4.35%
- Month Change
- 2.80%
- 6 Months Change
- 197.30%
- Year Change
- -36.42%
31 August, Sunday